[1] | Adaskevich V.P., Myadelets O.D., Tikhonovskaya I.V. Alopecia. M -2000. -187 p. |
[2] | Birch M. P., Messenger J. F., Messenger A. G. Hair density, hair diameter and the prevalence of female pattern hair loss // Br. J. Dermatol. – 2001. – Vol. 144. – P. 297–304. |
[3] | Birch M. P., Messenger A. G. Genetic factors predispose to balding and non–balding in men // Eur. J. Dermatol. – 2001.– Vol. 11. – P. 309–314. |
[4] | Blaumeiser B, van der Goot I, Fimmers R, et al. Familial aggregation of alopecia areata. // J Am Acad Dermatol. 2006; 54(4): 627–632. |
[5] | Cetin ED, Savk E, Uslu M, Eskin M, Karul A. Investigation of the inflammatory mechanisms in alopecia areata. // Am J Dermatopathol. 2009; 31(1): 53–60. |
[6] | Christoph T, Muller-Rover S, Audring H, et al. The human hair follicle immune system: cellular composition and immune privilege // Br J Dermatol. 2000; 142(5): 862–873. |
[7] | Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. // J Am Acad Dermatol. 2011; 65(5): 949–956. |
[8] | Colombe L., Michelet J.F., Bernard B.A., Prostanoid receptors in anagen human hair follicles. Experimental Dermatology, 2008. 17(1): p. 63-72. |
[9] | Cross M.J., et al., VEGF-receptor signal transduction. Trends in Biochemical Sciences, 2003. 28: 488-94. |
[10] | Chu SY, Chen YJ, Tseng WC, et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study // Br J Dermatol. 2012; 166(3): 525–531. |
[11] | Conteduca G, Rossi A, Megiorni F, et al. Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with alopecia areata. // Clin Exp Med. 2014; 14(1): 91–97. |
[12] | Ding, L., Saunders, T. L., Enikolopov, G., Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457-462, 2012. |
[13] | Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. // J Clin Invest. 2007; 117(8): 2019–2027. |
[14] | Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history.// J Eur Acad Dermatol Venereol. 2006; 20(9): 1055–1060. |
[15] | Guttman-Yassky E(1), Ungar B(2), Noda S(3), Suprun M(4), Shroff A(5), Dutt R(5), Khattri S(5), Min M(5), Mansouri Y(5), Zheng X(3), Estrada YD(5), Singer GK(5), Suarez-Farinas M(6), Krueger JG(3), Lebwohl MG(5). Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism.// J Allergy Clin Immunol. 2016 Jan; 137(1): 301-4. doi: 10.1016/j.jaci.2015.11.001. Epub 2015 Nov 20. |
[16] | Guzmán-Sánchez DA, Villanueva-Quintero GD, Alfaro Alfaro N, McMichael A. A clinical study of alopecia areata in Mexico. Int J Dermatol. // 2007; 46(12): 1308–1310. |
[17] | Happle R., Diphencyprone for the Treatment of Alopecia Areata-More Data and New Aspects. Archives of Dermatolology, 2002. 138: p. 112-113. |
[18] | Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., Werb, Z., Rafii, S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 109: 625-637, 2002. |
[19] | Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. // JAMA Dermatol. 2013; 149(7): 789–794. |
[20] | Fricke Villasante AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. // Clin Cosmet Investig Dermatol. 2015 Jul 24; 8: 397-403. doi: 10.2147/CCID.S53985. |
[21] | Ортикбоев Ж.О., & Саипова Д.С. (2019). Влияние гипотериоза на ремоделирование миокарда левого желудочка у женщин. Евразийский кардиологический журнал, (S1), 271-272. |
[22] | Kakourou T, Karachristou K, Chrousos G. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity.// J Eur Acad Dermatol Venereol. 2007; 21(3): 356–359. |
[23] | Karadag AS, Ertugrul DT, Bilgili SG, Takci Z, Tutal E, Yilmaz H. Insulin resistance is increased in alopecia areata patients. // Cutan Ocul Toxicol. 2013; 32(2): 102–106. |
[24] | Kavak A, Yeşildal N, Parlak AH, et al. Alopecia areata in Turkey: demographic and clinical features.// J Eur Acad Dermatol Venereol. 2008; 22(8): 977–981. |
[25] | Kawano M., Komi-Kuramochi A, Asada M, Suzuki M. Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. //J Invest Dermatol. 2005 May; 124(5): 877-85. |
[26] | Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E. Alopecia areata prevalence by gender and age. // J Eur Acad Dermatol Venereol. 2009; 23(5): 572–573. |
[27] | Lundin M, Chawa S, Sachdev A, Bhanusali D, Seiffert-Sinha K, Sinha AA. Gender differences in alopecia areata. J Drugs Dermatol //2014; 13(4): 409–413. |
[28] | MacLean KJ, Tidman MJ. Alopecia areata: more than skin deep. // Practitioner. 2013; 257(1764): 29–32. |
[29] | Ramos PM(1), Brianezi G(2), Martins AC(2), Silva MG(2), Marques ME(2), Miot HA(1). Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation. // Int J Cosmet Sci. 2016 May 10. doi: 10.1111/ics.12341. |
[30] | Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. // Autoimmun Rev. 2015; 14(2): 81–89. |